Themis Medicare

Gujarat Themis Biosyn will be merged with Themis Medicare. The merger is subject to the approval of the secured creditors and shareholders of both companies, the stock exchanges, SEBI, NCLT, and other regulatory approvals. Themis Medicare will issue 118 shares for every 100 shares held by shareholders in Gujarat Themis Biosyn.

AstraZeneca Pharma

The pharmaceutical company will launch Breztri Aerosphere in January 2025 in India. Breztri Aerosphere is used to relieve symptoms and prevent exacerbations in adult patients with chronic obstructive pulmonary disease (COPD).

Shilpa Medicare

The company's subsidiary, Shilpa Pharma Lifesciences, received the Certificate of Suitability (CEP) from EDQM (European Directorate for the Quality of Medicines & Healthcare) for the API Octreotide. Octreotide is used to treat high levels of growth hormone caused by acromegaly.

PG Electroplast

The company's subsidiary, PG Technoplast, has signed a definitive agreement with Spiro Mobility to become an exclusive manufacturing partner for manufacturing the electric vehicles of Spiro Mobility (Africa’s largest EV player) in India.

ITI

The telecom manufacturing company has received a contract worth Rs 95 crore from the Uttarakhand government for the mining digital transformation & surveillance system (MDTSS) project.

GVK Power and Infrastructure

The company has been admitted into the Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code. It released the provisional list of prospective resolution applicants under CIRP, including Vedanta, Jindal Power, Shyam Sel and Power, JSW Energy, and Zeal Global Opportunities Fund.

GMR Airports Infrastructure

The company recorded passenger traffic of 1.07 crore in October, growing 9% YoY and 5% MoM, while aircraft movements stood at 71,598 for the month, rising 9% YoY and 7% MoM.

Waaree Energies Q2 (Consolidated YoY)

Profit grows 14.7% to Rs 361.6 crore Vs Rs 315.1 crore. Revenue increases 1% to Rs 3,574.4 crore Vs Rs 3,537.3 crore

Bulk Deals

Medplus Health Services

Franklin Templeton MF, Invesco India, and Kotak Small Cap Fund bought a 6% stake in Medplus at an average price of Rs 700 per share, amounting to Rs 502.23 crore. However, PI Opportunities Fund - I exited the company by selling its entire 5.77% shareholding at the same price, valued at Rs 482.55 crore, and SBI Mutual Fund offloaded a 0.83% stake at the same price, valued at Rs 70 crore.

Tilaknagar Industries

Societe Generale bought a 0.94% stake in Tilaknagar at an average price of Rs 338.65 per share, from BofA Securities Europe SA, valued at Rs 61.52 crore

Vikasdhan - Grow your Dhan with Vikasdhan

Disclaimer- not an investment advice, only for educational purpose. To read complete disclaimer, click on the link https://www.vikasdhan.com/disclaimer